Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Circulating Anti-Beta2-glycoprotein Antibodies and Endothelial Dysfunction

This study has been completed.
Information provided by (Responsible Party):
Joaquin de Haro, M.D., Hospital Universitario Getafe Identifier:
First received: March 26, 2013
Last updated: March 28, 2013
Last verified: March 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2012
  Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)